GlassScriptPhysician profile
Raja G Varma
NPI 1699775759
$9,479.45
in general payments reported to CMS, 2019-2025
37 companies · $2,024 in 2025
The $2,024 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $960 · 2020: $736 · 2021: $1,240 · 2022: $1,416 · 2023: $1,203 · 2024: $1,900 · 2025: $2,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,126.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $959.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $790.07 | 2020-2025 | Farxiga, Lokelma |
| Kestra Medical Technology Services, INC. | $686.93 | 2022-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $663.07 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $624.34 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $610.01 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $557.16 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $455.21 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $428.24 | 2021-2025 | Watchman Flx, Avvigo Guidance System |
| Esperion Therapeutics, INC. | $404.75 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.90 | 2019-2025 | Lifevest |
| Medtronic, INC. | $382.45 | 2021-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Pfizer INC. | $312.66 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $273.97 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $251.07 | 2019-2025 | Eliquis, Camzyos |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $217.58 | 2019-2021 | |
| Abbott Laboratories | $162.40 | 2019-2025 | Cardiomems, Jot Dx |
| Medtronic Vascular, INC. | $156.44 | 2019-2020 | |
| Edwards Lifesciences Corporation | $115.22 | 2023-2025 | Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $110.73 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Medicomp INC | $105.75 | 2023-2025 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $100.49 | 2019-2020 | |
| Scpharmaceuticals INC. | $98.59 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $79.33 | 2019-2021 | |
| Heartflow, INC. | $74.69 | 2022-2024 | Ffrct |
| Irhythm Technologies, INC. | $68.68 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $64.50 | 2021-2023 | Evkeeza |
| Baxter Healthcare | $56.27 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Exact Sciences Corporation | $50.62 | 2025 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $46.37 | 2025 | Flexitouch Plus, Nimbl |
| Lexicon Pharmaceuticals, INC. | $42.77 | 2023-2024 | Inpefa |
| Bardy Diagnostics, INC. | $32.71 | 2022 | |
| Braemar Manufacturing, LLC | $23.63 | 2019 | |
| Philips North America LLC | $20.39 | 2022 | |
| Allergan, INC. | $18.93 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $18.00 | 2025 | Rhythm Express |
| Cvrx, INC. | $15.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raja Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.